Search filters

List of works by Douglas Sipp

2010 International Forum on Stem Cells (November 11-13; Tianjin, China).

scientific article published in September 2011

Advocacy: How to hasten open access

scientific article

Bioethics in China: No wild east

scientific article

Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions.

scientific article published on 19 February 2018

Cell Churches and Stem Cell Marketing in South Korea and the United States

scientific article published on 23 May 2016

Challenges in the Regulation of Autologous Stem Cell Interventions in the United States

scientific article published on 01 January 2018

Challenges in the clinical application of induced pluripotent stem cells.

scientific article

Clear up this stem-cell mess

scientific article published in Nature

Conditional approval: Japan lowers the bar for regenerative medicine products

scientific article

Direct-to-consumer stem cell marketing and regulatory responses

scientific article published on 09 August 2013

Disclosure and management of research findings in stem cell research and banking: policy statement.

scientific article published in May 2012

Downgrading of regulation in regenerative medicine

scientific article published on 01 August 2019

Emerging stem cell ethics

scientific article published in Science

Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards.

scientific article

Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations.

scientific article

Ethical and policy issues in the clinical translation of stem cells: report of a focus session at the ISSCR Tenth Annual Meeting

scientific article published in December 2012

Global Distribution of Businesses Marketing Stem Cell-Based Interventions

scientific article

Global bionetworks and challenges in regulating autologous adult stem cells.

scientific article

Global challenges in stem cell research and the many roads ahead.

scientific article published on May 2011

Global update: Japan.

scientific article

Gold standards in the diamond age: the commodification of pluripotency

scientific article published in October 2009

Identity and ownership issues in the regulation of autologous cells

scientific article published on 8 November 2017

Industry Responsibilities in Tackling Direct-to-Consumer Marketing of Unproven Stem Cell Treatments.

scientific article

Issues in stem cells in Asia and SNAP decisions

scientific article published on 5 August 2009

Japan Strengthens Regenerative Medicine Oversight

scientific article published in February 2018

Japan-China merger puts growth in East Asia first

scientific article published on 01 August 2005

Japanese firms broaden investment focus to early biotech

scientific article published on 01 August 2004

Japanese giants renew interest in industrial biotech

scientific article published on 01 March 2005

Marketing of unproven stem cell-based interventions: A call to action

scientific article published on July 2017

Medicine. Monitoring and regulating offshore stem cell clinics

scientific article published on 01 March 2009

Millennium ends Takeda's US shopping spree

scientific article published on 01 June 2008

New IJH guidelines highlight greater transparency

scientific article published in April 2011

New ISSCR guidelines: clinical translation of stem cell research

scientific article published in The Lancet

New trends in cellular therapy

scientific article published on 17 September 2020

No Vacillation on HPV Vaccination.

scientific article published in March 2018

No borders, only frontiers: the Global Stem Cell Research Community and the ISSCR.

scientific article published in June 2007

Oversight for clinical uses of autologous adult stem cells: lessons from international regulations.

scientific article

Patients Beware: Commercialized Stem Cell Treatments on the Web

scientific article published on 17 June 2010

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).

scientific article

Policy: Global standards for stem-cell research

scientific article

Publishing SNP genotypes of human embryonic stem cell lines: policy statement of the International Stem Cell Forum Ethics Working Party

scientific article (publication date: September 2011)

Regulation: Sell help not hope

scientific article published in June 2014

Regulatory impacts on stem cell research in Japan.

scientific article published in May 2010

Rejuvenating Regenerative Medicine Regulation.

scientific article published on 10 January 2018

SCIENTIFIC COMMUNITY. Confronting stem cell hype

scientific article

Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines

scientific article published on 11 May 2016

Show drugs work before selling them.

scientific article

Stem Cell Businesses and Right to Try Laws

scientific article published on 01 September 2019

Stem cell stratagems in alternative medicine.

scientific article published on 31 March 2011

Stem cells. U.S. regulation of stem cells as medical products

scientific article

Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report

scientific article published on 01 November 2018

The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation.

scientific article

The malignant niche: safe spaces for toxic stem cell marketing.

scientific article published on 19 December 2017

The politics of evidence in online illness narratives: An analysis of crowdfunding for purported stem cell treatments

scientific article published on 19 February 2019

The unregulated commercialization of stem cell treatments: a global perspective.

scientific article published on October 2011

Undertested and Overpriced: Japan Issues First Conditional Approval of Stem Cell Product

scientific article published in April 2016